Institutional Ownership Sab Biotherapeutics Inc Wt Exp (SABSW)
This table provides information about the institutional ownership of Sab Biotherapeutics Inc Wt Exp (SABSW). We have compiled data on the 8 institutions that hold shares in the stock, with a total of 802,415 shares, which have been reported (via 13F filing form) to have a value of $24,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Lmr Partners LLP
London, X0 |
Aug 14, 2025 Q2 2025 |
539,588
shares
|
$16,187
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
146,439
shares
|
$4,393
0.0% of portfolio
|
Q2 2024
Reduced 1.68%
|
|
|
Clear Street LLC
|
Aug 13, 2025 Q2 2025 |
78,833
shares
|
$2,364
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Walleye Trading LLC
Plymouth, MN |
Aug 13, 2025 Q2 2025 |
31,863
shares
|
$955
0.0% of portfolio
|
Q1 2025
Reduced 17.8%
|
|
|
Wolverine Asset Management LLC
|
Aug 04, 2025 Q2 2025 |
4,620
shares
|
$138
0.0% of portfolio
|
Q1 2025
Reduced 46.62%
|
|
|
New Edge Advisors, LLC
New Orleans, LA |
Aug 14, 2025 Q2 2025 |
1,072
shares
|
$32
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|